Financials

Maryland's attorney general has filed a lawsuit seeking to enforce a subpoena the state sent Insys Therapeutics Inc as part of a probe into allegations the drugmaker deceptively marketed a fentanyl-based cancer pain medicine.

Feb 8 Maryland's attorney general has filed a
lawsuit seeking to enforce a subpoena the state sent Insys
Therapeutics Inc as part of an investigation into
allegations the drugmaker deceptively marketed a fentanyl-based
cancer pain medicine.

Insys Therapeutics Inc's legal woes deepened on Thursday as New York's attorney general filed a lawsuit seeking at least $75 million from the company, which he said deceptively promoted a fentanyl-based cancer pain medicine for unsafe uses.

Feb 1 Insys Therapeutics Inc's legal
woes deepened on Thursday as New York's attorney general filed a
lawsuit seeking at least $75 million from the company, which he
said deceptively promoted a fentanyl-based cancer pain medicine
for unsafe uses.

Feb 1 New York's attorney general on Thursday
filed a lawsuit against Insys Therapeutics Inc seeking
$75 million from the pharmaceutical company, which he said
deceptively promoted a powerful fentanyl-based cancer pain
medicine for unsafe uses.

A former Insys Therapeutics Inc employee accused of engaging in a scheme to pay medical practitioners kickbacks to prescribe a fentanyl-based treatment is seeking to bar U.S. prosecutors from referring to the "opioid crisis" at his trial.

Jan 11 A former Insys Therapeutics Inc
employee accused of engaging in a scheme to pay medical
practitioners kickbacks to prescribe a fentanyl-based treatment
is seeking to bar U.S. prosecutors from referring to the "opioid
crisis" at his trial.

Related Topics:

Reuters, the news and media division of Thomson Reuters, is the world’s largest international multimedia news provider reaching more than one billion people every day. Reuters provides trusted business, financial, national, and international news to professionals via Thomson Reuters desktops, the world's media organizations, and directly to consumers at Reuters.com and via Reuters TV. Learn more about Thomson Reuters products: